Phase I Study of Telatinib (BAY 57-9352): Analysis of Safety, Pharmacokinetics, Tumor Efficacy, and Biomarkers in Patients With Colorectal Cancer
Vascular Cell - United Kingdom
doi 10.1186/2045-824x-3-16
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2011
Authors
Publisher
Publiverse Online S.R.L